Navaneeth Narayanan

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Future microbiology

Antimicrobial agents and chemotherapy

Pharmacotherapy

Rutgers Robert Wood Johnson Medical School

Rutgers School of Public Health (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rutgers Robert Wood Johnson Medical School

United States

Adjunct Assistant Profesor :: Division of Infectious Diseases

Rutgers University Ernest Mario School of Pharmacy

United States

Clinical Assistant Professor :: Pharmacy Practice and Administration

Robert Wood Johnson University Hospital

United States

Infectious Diseases Clinical Pharmacist :: Pharmacy

Education History

Rutgers School of Public Health

United States

MSC :: Epidemiology

Rutgers University Ernest Mario School of Pharmacy

United States

PHD

Publications

Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo Elisandro Mendes, Paul H Edelstein
Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (2) (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin/clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, Nicholas M Moore, Christian G Giske, Rodrigo E Mendes, Paul H Edelstein
Amoxicillin-clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Yingda L Xie, Nisha Modi, Deborah Handler, Sijia Yu, Prakruti Rao, Leonid Kagan, Kristen Petros de Guex, Robert Reiss, Anna Siemiątkowska, Anshika Narang, Navaneeth Narayanan, Jasie Hearn, Amanda Khalil, Patricia Woods, Laura Young, Alfred Lardizabal, Selvakumar Subbian, Charles A Peloquin, Christopher Vinnard, Tania A Thomas, Scott K Heysell
Simplified urine-based method to detect rifampin underexposure in adults with tuberculosis: a prospective diagnostic accuracy study. Antimicrobial agents and chemotherapy (2023)
Navaneeth Narayanan, James S Lewis
Aminoglycoside Therapeutic Drug Monitoring: On Paper versus In Practice. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Erin K McCreary, Matthew R Davis, Navaneeth Narayanan, David R Andes, Dario Cattaneo, Robbie Christian, Russell E Lewis, Kevin M Watt, Nathan P Wiederhold, Melissa D Johnson
Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2023)
Navaneeth Narayanan, Tiffany Lin, David Vinarov, Thomas Bucek, Liya Johnson, Cheryl Mathew, Saira Chaudhry, Luigi Brunetti
Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults. Infection and drug resistance 14 (2021)
Navaneeth Narayanan, Nupur Gulati, Bishakha Ghoshal, Kristina Feja, Amisha Malhotra, Rajita Bhavaraju, Arpita Jindani, Sunanda Gaur, Sabah Kalyoussef
Latent Tuberculosis Infection Beliefs and Testing and Treatment Health Behaviors Amongst Non-US-Born South Asians in New Jersey: A Cross-Sectional Community Survey. Journal of community health 44 (4) (2020)
Navaneeth Narayanan, Rena Rai, Parth Vaidya, Avani Desai, Tanaya Bhowmick, Melvin P Weinstein
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia. Therapeutic advances in infectious disease 6 (2019)
Shaili Adani, Tanaya Bhowmick, Melvin P Weinstein, Navaneeth Narayanan
Impact of Vancomycin MIC on Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting. Antimicrobial agents and chemotherapy 62 (4) (2018)
Navaneeth Narayanan, Clifton R Lacy, Joseph E Cruz, Meghan Nahass, Jonathan Karp, Joseph A Barone, Evelyn R Hermes-DeSantis
Disaster Preparedness: Biological Threats and Treatment Options. Pharmacotherapy 38 (2) (2018)

Navaneeth Narayanan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Navaneeth Narayanan